| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 61 | 2025 | 431 | 16.570 |
Why?
|
| Obsessive-Compulsive Disorder | 36 | 2025 | 831 | 9.690 |
Why?
|
| Gyrus Cinguli | 18 | 2025 | 131 | 5.340 |
Why?
|
| Electroencephalography | 38 | 2025 | 906 | 4.030 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 7 | 2024 | 128 | 3.720 |
Why?
|
| Prefrontal Cortex | 13 | 2025 | 218 | 3.680 |
Why?
|
| Brain | 45 | 2025 | 3198 | 3.230 |
Why?
|
| Neurosurgical Procedures | 18 | 2025 | 316 | 3.120 |
Why?
|
| Subthalamic Nucleus | 9 | 2022 | 62 | 2.800 |
Why?
|
| Brain Mapping | 32 | 2025 | 406 | 2.730 |
Why?
|
| Internal Capsule | 9 | 2023 | 51 | 2.650 |
Why?
|
| Psychosurgery | 8 | 2023 | 27 | 2.590 |
Why?
|
| Nerve Net | 9 | 2025 | 264 | 2.540 |
Why?
|
| Parkinson Disease | 11 | 2022 | 739 | 2.370 |
Why?
|
| Neurosurgery | 8 | 2025 | 79 | 2.280 |
Why?
|
| Epilepsy | 18 | 2025 | 891 | 2.240 |
Why?
|
| Neurons | 27 | 2025 | 2017 | 2.140 |
Why?
|
| Drug Resistant Epilepsy | 13 | 2025 | 235 | 1.990 |
Why?
|
| Electrocorticography | 12 | 2025 | 74 | 1.940 |
Why?
|
| Radiosurgery | 7 | 2023 | 147 | 1.830 |
Why?
|
| Epilepsy, Temporal Lobe | 6 | 2023 | 91 | 1.810 |
Why?
|
| Humans | 208 | 2025 | 132348 | 1.770 |
Why?
|
| Neocortex | 3 | 2023 | 74 | 1.640 |
Why?
|
| Stereotaxic Techniques | 8 | 2025 | 79 | 1.560 |
Why?
|
| Somatosensory Cortex | 8 | 2014 | 57 | 1.510 |
Why?
|
| Ventral Striatum | 6 | 2025 | 43 | 1.500 |
Why?
|
| Seizures | 16 | 2023 | 895 | 1.490 |
Why?
|
| Depressive Disorder, Major | 4 | 2025 | 461 | 1.490 |
Why?
|
| Connectome | 7 | 2025 | 122 | 1.450 |
Why?
|
| Neurophysiology | 3 | 2024 | 19 | 1.260 |
Why?
|
| Mental Disorders | 7 | 2024 | 893 | 1.230 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2025 | 128 | 1.220 |
Why?
|
| Cost-Benefit Analysis | 4 | 2025 | 557 | 1.200 |
Why?
|
| Beta Rhythm | 2 | 2025 | 28 | 1.160 |
Why?
|
| Brain Waves | 5 | 2022 | 47 | 1.140 |
Why?
|
| Parietal Lobe | 4 | 2025 | 48 | 1.120 |
Why?
|
| Hippocampus | 11 | 2025 | 819 | 1.100 |
Why?
|
| Diffusion Tensor Imaging | 5 | 2023 | 253 | 1.100 |
Why?
|
| Reward | 4 | 2024 | 116 | 1.090 |
Why?
|
| Brain Neoplasms | 14 | 2024 | 1409 | 1.080 |
Why?
|
| Cognition | 10 | 2022 | 814 | 1.070 |
Why?
|
| Treatment Outcome | 35 | 2025 | 13017 | 1.060 |
Why?
|
| Mental Recall | 11 | 2024 | 144 | 1.050 |
Why?
|
| Neurosciences | 4 | 2024 | 52 | 1.040 |
Why?
|
| Thalamus | 3 | 2024 | 88 | 1.020 |
Why?
|
| Middle Aged | 65 | 2025 | 28891 | 1.000 |
Why?
|
| Electrodes, Implanted | 13 | 2024 | 175 | 1.000 |
Why?
|
| Male | 95 | 2025 | 65061 | 0.990 |
Why?
|
| Memory, Episodic | 7 | 2024 | 28 | 0.990 |
Why?
|
| Septal Nuclei | 2 | 2023 | 14 | 0.990 |
Why?
|
| Adult | 69 | 2025 | 31619 | 0.990 |
Why?
|
| Magnetic Resonance Imaging | 26 | 2025 | 3853 | 0.950 |
Why?
|
| Neural Pathways | 9 | 2025 | 281 | 0.880 |
Why?
|
| Female | 85 | 2025 | 70795 | 0.860 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2023 | 80 | 0.840 |
Why?
|
| Visual Perception | 5 | 2025 | 136 | 0.830 |
Why?
|
| Implantable Neurostimulators | 2 | 2020 | 20 | 0.820 |
Why?
|
| Limbic System | 2 | 2013 | 22 | 0.810 |
Why?
|
| Tourette Syndrome | 2 | 2023 | 158 | 0.810 |
Why?
|
| Tremor | 1 | 2024 | 136 | 0.800 |
Why?
|
| Pituitary ACTH Hypersecretion | 2 | 2012 | 9 | 0.770 |
Why?
|
| Young Adult | 36 | 2025 | 9945 | 0.760 |
Why?
|
| Frontal Lobe | 5 | 2025 | 120 | 0.760 |
Why?
|
| Craniotomy | 4 | 2019 | 105 | 0.720 |
Why?
|
| Alpha Rhythm | 1 | 2021 | 9 | 0.720 |
Why?
|
| Signal Processing, Computer-Assisted | 5 | 2025 | 132 | 0.720 |
Why?
|
| Psychomotor Performance | 4 | 2025 | 182 | 0.710 |
Why?
|
| Functional Laterality | 3 | 2025 | 195 | 0.690 |
Why?
|
| Speech Perception | 5 | 2025 | 57 | 0.690 |
Why?
|
| Movement Disorders | 2 | 2013 | 223 | 0.690 |
Why?
|
| Robotics | 1 | 2022 | 108 | 0.680 |
Why?
|
| Electric Stimulation | 10 | 2025 | 251 | 0.670 |
Why?
|
| Depression | 4 | 2023 | 1351 | 0.650 |
Why?
|
| Photic Stimulation | 8 | 2025 | 235 | 0.640 |
Why?
|
| Action Potentials | 8 | 2022 | 489 | 0.640 |
Why?
|
| Cerebrovascular Circulation | 10 | 2008 | 475 | 0.640 |
Why?
|
| Temporal Lobe | 6 | 2025 | 118 | 0.630 |
Why?
|
| Memory | 7 | 2022 | 355 | 0.620 |
Why?
|
| Spatial Memory | 5 | 2020 | 31 | 0.610 |
Why?
|
| Cerebral Cortex | 9 | 2024 | 482 | 0.610 |
Why?
|
| Central Nervous System Neoplasms | 5 | 2020 | 215 | 0.580 |
Why?
|
| Electrodes | 8 | 2024 | 91 | 0.580 |
Why?
|
| Evoked Potentials, Somatosensory | 3 | 2014 | 37 | 0.560 |
Why?
|
| Time Factors | 11 | 2021 | 6456 | 0.560 |
Why?
|
| Quality of Life | 5 | 2024 | 2151 | 0.560 |
Why?
|
| Electrophysiology | 7 | 2025 | 269 | 0.550 |
Why?
|
| White Matter | 4 | 2022 | 211 | 0.550 |
Why?
|
| Auditory Cortex | 4 | 2024 | 28 | 0.550 |
Why?
|
| Neuroimaging | 7 | 2023 | 375 | 0.540 |
Why?
|
| Artifacts | 6 | 2025 | 116 | 0.540 |
Why?
|
| Foramen Ovale | 2 | 2014 | 4 | 0.530 |
Why?
|
| Gamma Rhythm | 4 | 2021 | 14 | 0.510 |
Why?
|
| Quadriplegia | 1 | 2016 | 38 | 0.510 |
Why?
|
| Evoked Potentials | 7 | 2025 | 121 | 0.510 |
Why?
|
| Epilepsies, Partial | 3 | 2022 | 95 | 0.490 |
Why?
|
| Neurofeedback | 1 | 2015 | 5 | 0.490 |
Why?
|
| Microelectrodes | 6 | 2025 | 43 | 0.490 |
Why?
|
| Hand | 1 | 2016 | 107 | 0.480 |
Why?
|
| Reaction Time | 7 | 2021 | 168 | 0.470 |
Why?
|
| Task Performance and Analysis | 6 | 2021 | 88 | 0.460 |
Why?
|
| Basal Ganglia | 3 | 2013 | 63 | 0.460 |
Why?
|
| Individuality | 1 | 2015 | 37 | 0.460 |
Why?
|
| Visual Cortex | 3 | 2021 | 132 | 0.460 |
Why?
|
| Neuralgia | 1 | 2015 | 49 | 0.450 |
Why?
|
| Behavior | 3 | 2024 | 74 | 0.440 |
Why?
|
| Monte Carlo Method | 2 | 2025 | 102 | 0.430 |
Why?
|
| Spatial Navigation | 3 | 2018 | 23 | 0.430 |
Why?
|
| Entorhinal Cortex | 3 | 2019 | 22 | 0.430 |
Why?
|
| Essential Tremor | 3 | 2024 | 94 | 0.430 |
Why?
|
| Occipital Lobe | 1 | 2014 | 34 | 0.420 |
Why?
|
| Laser Therapy | 3 | 2023 | 232 | 0.420 |
Why?
|
| Acoustic Stimulation | 3 | 2025 | 85 | 0.420 |
Why?
|
| Nasal Lavage | 1 | 2013 | 3 | 0.410 |
Why?
|
| Myiasis | 1 | 2013 | 7 | 0.410 |
Why?
|
| Neurilemmoma | 1 | 2014 | 46 | 0.410 |
Why?
|
| Microsurgery | 1 | 2014 | 65 | 0.410 |
Why?
|
| Motor Cortex | 3 | 2024 | 85 | 0.400 |
Why?
|
| Optics and Photonics | 4 | 2008 | 124 | 0.400 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 651 | 0.400 |
Why?
|
| Glioblastoma | 5 | 2017 | 374 | 0.400 |
Why?
|
| Aged | 29 | 2022 | 21381 | 0.390 |
Why?
|
| Nasal Cavity | 1 | 2013 | 52 | 0.390 |
Why?
|
| Space Perception | 3 | 2024 | 59 | 0.390 |
Why?
|
| Glioma | 3 | 2024 | 534 | 0.390 |
Why?
|
| Petrosal Sinus Sampling | 1 | 2012 | 2 | 0.390 |
Why?
|
| Schizophrenia | 1 | 2015 | 332 | 0.380 |
Why?
|
| Neuroma, Acoustic | 1 | 2012 | 32 | 0.370 |
Why?
|
| Retrospective Studies | 27 | 2023 | 17364 | 0.360 |
Why?
|
| Nose | 1 | 2012 | 103 | 0.360 |
Why?
|
| Autistic Disorder | 1 | 2015 | 387 | 0.360 |
Why?
|
| Lymphoma | 3 | 2020 | 331 | 0.350 |
Why?
|
| Association Learning | 1 | 2011 | 23 | 0.350 |
Why?
|
| Endoscopy | 1 | 2013 | 281 | 0.350 |
Why?
|
| Speech | 2 | 2025 | 79 | 0.350 |
Why?
|
| Attention | 4 | 2024 | 200 | 0.350 |
Why?
|
| Spectrum Analysis | 2 | 2008 | 69 | 0.340 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2018 | 390 | 0.340 |
Why?
|
| Brain Diseases | 2 | 2013 | 307 | 0.340 |
Why?
|
| United States | 7 | 2025 | 11628 | 0.340 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 278 | 0.340 |
Why?
|
| Postoperative Complications | 6 | 2017 | 3139 | 0.330 |
Why?
|
| Decision Making | 6 | 2018 | 693 | 0.320 |
Why?
|
| Verbal Learning | 3 | 2022 | 71 | 0.320 |
Why?
|
| Theta Rhythm | 2 | 2020 | 24 | 0.310 |
Why?
|
| Choice Behavior | 2 | 2024 | 132 | 0.300 |
Why?
|
| Electrophysiological Phenomena | 3 | 2025 | 65 | 0.300 |
Why?
|
| Neuropsychological Tests | 5 | 2022 | 989 | 0.300 |
Why?
|
| Health Care Costs | 2 | 2024 | 407 | 0.290 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2008 | 94 | 0.280 |
Why?
|
| Oxygen | 5 | 2008 | 572 | 0.280 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 672 | 0.280 |
Why?
|
| Hemangiopericytoma | 2 | 2018 | 9 | 0.280 |
Why?
|
| Ultrasonography, Doppler | 1 | 2008 | 186 | 0.280 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 7111 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2008 | 1227 | 0.270 |
Why?
|
| Functional Neuroimaging | 2 | 2020 | 35 | 0.260 |
Why?
|
| Amygdala | 2 | 2025 | 85 | 0.260 |
Why?
|
| Adolescent | 19 | 2025 | 20553 | 0.260 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2024 | 82 | 0.260 |
Why?
|
| Heart Atria | 1 | 2008 | 333 | 0.250 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 5405 | 0.240 |
Why?
|
| Severity of Illness Index | 6 | 2024 | 3087 | 0.240 |
Why?
|
| Algorithms | 9 | 2023 | 1722 | 0.240 |
Why?
|
| Preoperative Care | 3 | 2019 | 370 | 0.240 |
Why?
|
| Saccades | 1 | 2025 | 21 | 0.240 |
Why?
|
| Animals | 20 | 2024 | 34995 | 0.240 |
Why?
|
| Information Dissemination | 2 | 2024 | 199 | 0.240 |
Why?
|
| Eye Movements | 1 | 2025 | 79 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1303 | 0.230 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 4 | 0.230 |
Why?
|
| Creativity | 1 | 2024 | 14 | 0.220 |
Why?
|
| Brain Injuries | 4 | 2015 | 715 | 0.220 |
Why?
|
| Thinking | 1 | 2024 | 34 | 0.220 |
Why?
|
| Memory Disorders | 2 | 2016 | 209 | 0.220 |
Why?
|
| Periodicity | 1 | 2024 | 51 | 0.220 |
Why?
|
| Electric Power Supplies | 1 | 2024 | 18 | 0.220 |
Why?
|
| Executive Function | 1 | 2025 | 127 | 0.220 |
Why?
|
| Prognosis | 8 | 2024 | 5010 | 0.220 |
Why?
|
| Sample Size | 1 | 2024 | 88 | 0.210 |
Why?
|
| Rats | 8 | 2008 | 3620 | 0.210 |
Why?
|
| Neurophysiological Monitoring | 1 | 2024 | 37 | 0.210 |
Why?
|
| Neurotransmitter Agents | 1 | 2024 | 144 | 0.210 |
Why?
|
| Uncertainty | 2 | 2022 | 103 | 0.210 |
Why?
|
| Data Compression | 1 | 2023 | 12 | 0.200 |
Why?
|
| Hemodynamics | 2 | 2005 | 860 | 0.200 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 440 | 0.200 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 308 | 0.200 |
Why?
|
| Color Perception | 2 | 2021 | 12 | 0.200 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 2145 | 0.200 |
Why?
|
| Parents | 2 | 2021 | 1076 | 0.200 |
Why?
|
| Spinal Cord | 1 | 2024 | 274 | 0.200 |
Why?
|
| Cohort Studies | 7 | 2020 | 5150 | 0.200 |
Why?
|
| Electromagnetic Fields | 1 | 2022 | 26 | 0.190 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2012 | 74 | 0.190 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 332 | 0.190 |
Why?
|
| Levodopa | 1 | 2022 | 94 | 0.190 |
Why?
|
| Orientation, Spatial | 1 | 2021 | 7 | 0.190 |
Why?
|
| Scalp | 1 | 2022 | 57 | 0.180 |
Why?
|
| Hemoglobins | 4 | 2008 | 322 | 0.180 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 2303 | 0.180 |
Why?
|
| Phosphenes | 1 | 2021 | 4 | 0.180 |
Why?
|
| Psychotropic Drugs | 1 | 2022 | 129 | 0.180 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 688 | 0.180 |
Why?
|
| Decision Support Techniques | 1 | 2025 | 311 | 0.180 |
Why?
|
| Workflow | 1 | 2022 | 134 | 0.180 |
Why?
|
| Wakefulness | 1 | 2022 | 105 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2025 | 323 | 0.180 |
Why?
|
| Blood Volume | 4 | 2005 | 81 | 0.180 |
Why?
|
| Pyramidal Cells | 1 | 2022 | 167 | 0.180 |
Why?
|
| Fluorescein | 2 | 2018 | 39 | 0.180 |
Why?
|
| Phantoms, Imaging | 3 | 2025 | 147 | 0.170 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 277 | 0.170 |
Why?
|
| Corpus Callosum | 1 | 2021 | 104 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 1247 | 0.170 |
Why?
|
| Research Personnel | 1 | 2022 | 136 | 0.170 |
Why?
|
| Hearing Aids | 2 | 2017 | 32 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 615 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 59 | 0.160 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 2683 | 0.160 |
Why?
|
| Unsupervised Machine Learning | 1 | 2019 | 13 | 0.160 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2019 | 5 | 0.160 |
Why?
|
| Models, Neurological | 2 | 2021 | 218 | 0.160 |
Why?
|
| Virtual Reality | 1 | 2020 | 34 | 0.160 |
Why?
|
| Psychiatry | 1 | 2023 | 271 | 0.160 |
Why?
|
| Perception | 1 | 2021 | 237 | 0.150 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2019 | 58 | 0.150 |
Why?
|
| Computer Simulation | 4 | 2025 | 699 | 0.150 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 3023 | 0.150 |
Why?
|
| Grid Cells | 1 | 2018 | 3 | 0.150 |
Why?
|
| Medicare | 1 | 2022 | 448 | 0.150 |
Why?
|
| Membrane Potentials | 1 | 2019 | 302 | 0.150 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2018 | 16 | 0.140 |
Why?
|
| Time Perception | 1 | 2018 | 11 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2018 | 43 | 0.140 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2018 | 7 | 0.140 |
Why?
|
| Gliosarcoma | 1 | 2017 | 10 | 0.140 |
Why?
|
| Oxyhemoglobins | 2 | 2008 | 25 | 0.140 |
Why?
|
| Risk-Taking | 1 | 2018 | 101 | 0.140 |
Why?
|
| Decompressive Craniectomy | 2 | 2015 | 15 | 0.140 |
Why?
|
| Patient Preference | 1 | 2019 | 135 | 0.140 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1648 | 0.140 |
Why?
|
| Device Removal | 1 | 2019 | 225 | 0.140 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 311 | 0.140 |
Why?
|
| Hindlimb | 3 | 2008 | 80 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 460 | 0.140 |
Why?
|
| Movement | 1 | 2018 | 169 | 0.130 |
Why?
|
| Ethics, Research | 2 | 2019 | 55 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 483 | 0.130 |
Why?
|
| Efferent Pathways | 2 | 2014 | 9 | 0.130 |
Why?
|
| Macaca mulatta | 3 | 2020 | 506 | 0.130 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 1451 | 0.130 |
Why?
|
| Fornix, Brain | 1 | 2016 | 19 | 0.120 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 21 | 0.120 |
Why?
|
| Child | 11 | 2023 | 25827 | 0.120 |
Why?
|
| Health Personnel | 1 | 2020 | 546 | 0.120 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 353 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 1 | 2016 | 84 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1153 | 0.120 |
Why?
|
| Surgical Wound Infection | 2 | 2015 | 271 | 0.120 |
Why?
|
| Dacarbazine | 1 | 2015 | 99 | 0.120 |
Why?
|
| Cranial Irradiation | 1 | 2015 | 72 | 0.120 |
Why?
|
| Leukocytosis | 1 | 2015 | 48 | 0.120 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2015 | 103 | 0.120 |
Why?
|
| Mental Processes | 2 | 2021 | 39 | 0.120 |
Why?
|
| Pain Perception | 1 | 2015 | 5 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 663 | 0.110 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 106 | 0.110 |
Why?
|
| Drug Resistance | 1 | 2015 | 252 | 0.110 |
Why?
|
| Forecasting | 2 | 2013 | 373 | 0.110 |
Why?
|
| International Cooperation | 1 | 2015 | 166 | 0.110 |
Why?
|
| Dopamine | 1 | 2015 | 252 | 0.110 |
Why?
|
| Hypothalamus | 1 | 2016 | 210 | 0.110 |
Why?
|
| Dominance, Cerebral | 1 | 2014 | 55 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 218 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 506 | 0.110 |
Why?
|
| Evoked Potentials, Motor | 1 | 2014 | 34 | 0.110 |
Why?
|
| Vibrissae | 2 | 2004 | 13 | 0.110 |
Why?
|
| Biological Clocks | 1 | 2013 | 29 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2023 | 6540 | 0.100 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2013 | 21 | 0.100 |
Why?
|
| Physical Stimulation | 2 | 2004 | 39 | 0.100 |
Why?
|
| Dura Mater | 1 | 2013 | 26 | 0.100 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2013 | 20 | 0.100 |
Why?
|
| Globus Pallidus | 1 | 2013 | 69 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2019 | 553 | 0.100 |
Why?
|
| Paranasal Sinuses | 1 | 2013 | 17 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 132 | 0.100 |
Why?
|
| Brain Edema | 1 | 2013 | 71 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 212 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 261 | 0.100 |
Why?
|
| Boston | 1 | 2013 | 122 | 0.100 |
Why?
|
| Hypernatremia | 1 | 2013 | 32 | 0.100 |
Why?
|
| Emotions | 2 | 2023 | 367 | 0.100 |
Why?
|
| Skull Base Neoplasms | 1 | 2013 | 36 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2013 | 3710 | 0.100 |
Why?
|
| Benchmarking | 2 | 2024 | 137 | 0.100 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2013 | 61 | 0.100 |
Why?
|
| Fever | 1 | 2015 | 312 | 0.100 |
Why?
|
| Lasers | 2 | 2023 | 118 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 855 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 165 | 0.100 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 161 | 0.100 |
Why?
|
| Intracranial Aneurysm | 1 | 2013 | 85 | 0.100 |
Why?
|
| Dystonic Disorders | 1 | 2013 | 94 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 273 | 0.090 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2012 | 57 | 0.090 |
Why?
|
| Operative Time | 1 | 2013 | 192 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 741 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2016 | 297 | 0.090 |
Why?
|
| Biomarkers | 4 | 2024 | 3391 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2015 | 681 | 0.090 |
Why?
|
| Nucleus Accumbens | 1 | 2012 | 56 | 0.090 |
Why?
|
| Research Report | 1 | 2012 | 72 | 0.090 |
Why?
|
| Pituitary Gland | 1 | 2012 | 81 | 0.090 |
Why?
|
| Cues | 1 | 2012 | 101 | 0.090 |
Why?
|
| Auditory Perception | 2 | 2025 | 41 | 0.090 |
Why?
|
| Conflict of Interest | 1 | 2012 | 68 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 1 | 2015 | 549 | 0.090 |
Why?
|
| Otologic Surgical Procedures | 1 | 2012 | 25 | 0.090 |
Why?
|
| Spine | 1 | 2012 | 146 | 0.090 |
Why?
|
| Workload | 1 | 2013 | 150 | 0.090 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 722 | 0.090 |
Why?
|
| Pituitary Neoplasms | 1 | 2012 | 83 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2012 | 235 | 0.090 |
Why?
|
| Meningioma | 1 | 2013 | 140 | 0.090 |
Why?
|
| Intraoperative Awareness | 1 | 2011 | 2 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2012 | 220 | 0.090 |
Why?
|
| Safety Management | 1 | 2012 | 121 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2013 | 215 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2015 | 1229 | 0.080 |
Why?
|
| Survival Rate | 4 | 2018 | 2187 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2013 | 241 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 1126 | 0.080 |
Why?
|
| Prevalence | 2 | 2015 | 2665 | 0.080 |
Why?
|
| Hydrocephalus | 2 | 2013 | 276 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2018 | 1570 | 0.080 |
Why?
|
| Cerebellum | 1 | 2013 | 463 | 0.080 |
Why?
|
| Risk Factors | 3 | 2019 | 10911 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2013 | 571 | 0.080 |
Why?
|
| Jugular Veins | 1 | 2008 | 76 | 0.070 |
Why?
|
| Central Nervous System | 2 | 2021 | 284 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2020 | 166 | 0.070 |
Why?
|
| Intraoperative Period | 3 | 2016 | 71 | 0.070 |
Why?
|
| Stroke | 2 | 2015 | 1068 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 554 | 0.070 |
Why?
|
| Carotid Arteries | 1 | 2008 | 136 | 0.070 |
Why?
|
| Disease Management | 1 | 2012 | 565 | 0.070 |
Why?
|
| Culture | 1 | 2008 | 72 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 3980 | 0.070 |
Why?
|
| Catheters, Indwelling | 1 | 2008 | 157 | 0.070 |
Why?
|
| Pseudotumor Cerebri | 1 | 2008 | 66 | 0.070 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1683 | 0.070 |
Why?
|
| Contrast Media | 3 | 2016 | 508 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2008 | 801 | 0.060 |
Why?
|
| Language | 1 | 2008 | 225 | 0.060 |
Why?
|
| Physicians | 1 | 2013 | 635 | 0.060 |
Why?
|
| Anesthesia | 1 | 2008 | 208 | 0.060 |
Why?
|
| Fixation, Ocular | 1 | 2025 | 18 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2013 | 1071 | 0.060 |
Why?
|
| Cognitive Science | 1 | 2005 | 2 | 0.060 |
Why?
|
| Sound | 1 | 2025 | 22 | 0.060 |
Why?
|
| Cortical Spreading Depression | 1 | 2005 | 10 | 0.060 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2024 | 52 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 34 | 0.060 |
Why?
|
| Bias | 1 | 2025 | 144 | 0.050 |
Why?
|
| Pupil | 1 | 2024 | 56 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2004 | 52 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2005 | 153 | 0.050 |
Why?
|
| Sheep | 1 | 2024 | 229 | 0.050 |
Why?
|
| Biopsy | 2 | 2019 | 1289 | 0.050 |
Why?
|
| Ecosystem | 1 | 2024 | 107 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 142 | 0.050 |
Why?
|
| Forelimb | 1 | 2003 | 15 | 0.050 |
Why?
|
| Transcriptome | 2 | 2024 | 1125 | 0.050 |
Why?
|
| Mutation | 3 | 2024 | 6248 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 38 | 0.050 |
Why?
|
| Microglia | 1 | 2024 | 138 | 0.050 |
Why?
|
| Microcirculation | 1 | 2004 | 117 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 1297 | 0.050 |
Why?
|
| Memory, Short-Term | 2 | 2019 | 142 | 0.050 |
Why?
|
| Light | 1 | 2023 | 184 | 0.050 |
Why?
|
| Electromagnetic Radiation | 1 | 2022 | 4 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1443 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 1368 | 0.050 |
Why?
|
| Affect | 1 | 2023 | 173 | 0.050 |
Why?
|
| Support Vector Machine | 1 | 2022 | 23 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 443 | 0.050 |
Why?
|
| Linear Models | 1 | 2004 | 713 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2022 | 3422 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 449 | 0.050 |
Why?
|
| Tomography, Spiral Computed | 1 | 2021 | 15 | 0.050 |
Why?
|
| Semantics | 1 | 2021 | 28 | 0.040 |
Why?
|
| Morals | 1 | 2022 | 73 | 0.040 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2020 | 3 | 0.040 |
Why?
|
| Wavelet Analysis | 1 | 2020 | 6 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2022 | 249 | 0.040 |
Why?
|
| Interneurons | 1 | 2022 | 147 | 0.040 |
Why?
|
| Logistic Models | 2 | 2018 | 1840 | 0.040 |
Why?
|
| Blindness | 1 | 2021 | 76 | 0.040 |
Why?
|
| Biological Variation, Population | 1 | 2020 | 26 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 328 | 0.040 |
Why?
|
| Swine | 1 | 2024 | 1197 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2025 | 988 | 0.040 |
Why?
|
| Gray Matter | 1 | 2020 | 44 | 0.040 |
Why?
|
| Biomedical Engineering | 1 | 2019 | 24 | 0.040 |
Why?
|
| History, 20th Century | 2 | 2012 | 387 | 0.040 |
Why?
|
| Verbal Behavior | 1 | 2019 | 52 | 0.040 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2019 | 16 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 105 | 0.040 |
Why?
|
| Place Cells | 1 | 2019 | 18 | 0.040 |
Why?
|
| Vocabulary | 1 | 2019 | 23 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 494 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 826 | 0.040 |
Why?
|
| Magnetoencephalography | 1 | 2018 | 46 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 8 | 0.040 |
Why?
|
| Sclerosis | 1 | 2018 | 38 | 0.040 |
Why?
|
| Incidence | 2 | 2018 | 3362 | 0.040 |
Why?
|
| Sleep | 1 | 2021 | 370 | 0.040 |
Why?
|
| Drainage | 1 | 2019 | 265 | 0.030 |
Why?
|
| Malformations of Cortical Development | 1 | 2018 | 54 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1502 | 0.030 |
Why?
|
| Machine Learning | 1 | 2021 | 347 | 0.030 |
Why?
|
| Software | 1 | 2022 | 729 | 0.030 |
Why?
|
| Noise | 1 | 2017 | 21 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2017 | 34 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 134 | 0.030 |
Why?
|
| Margins of Excision | 1 | 2016 | 57 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 343 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 65 | 0.030 |
Why?
|
| New York | 1 | 2015 | 72 | 0.030 |
Why?
|
| Propionibacterium acnes | 1 | 2015 | 14 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 447 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 250 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2015 | 89 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2015 | 237 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 2016 | 169 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2015 | 125 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 324 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 598 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2015 | 79 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2013 | 2169 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 433 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 44 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 137 | 0.030 |
Why?
|
| Time | 1 | 2013 | 100 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2015 | 192 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 75 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2013 | 52 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 1086 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1230 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2012 | 120 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 445 | 0.020 |
Why?
|
| Glasgow Outcome Scale | 1 | 2012 | 48 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2012 | 89 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2013 | 212 | 0.020 |
Why?
|
| Pain | 1 | 2015 | 461 | 0.020 |
Why?
|
| Fatigue | 1 | 2013 | 198 | 0.020 |
Why?
|
| Mood Disorders | 1 | 2012 | 129 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 406 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 307 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 585 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2228 | 0.020 |
Why?
|
| Compassionate Use Trials | 1 | 2010 | 15 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2010 | 31 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 2931 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 197 | 0.020 |
Why?
|
| Infant | 2 | 2015 | 13195 | 0.020 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2008 | 33 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2015 | 14857 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 550 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 491 | 0.020 |
Why?
|
| Judgment | 1 | 2008 | 38 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 564 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2012 | 1076 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2007 | 118 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 730 | 0.020 |
Why?
|
| Species Specificity | 1 | 2007 | 544 | 0.020 |
Why?
|
| Vasomotor System | 1 | 2005 | 21 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2005 | 106 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 254 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7567 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 4767 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 18572 | 0.000 |
Why?
|